Voclosporin Patent Expiration

Voclosporin is Used for the treatment of active lupus nephritis. It was first introduced by Aurinia Pharmaceuticals Inc in its drug Lupkynis on Jan 22, 2021.


Voclosporin Patents

Given below is the list of patents protecting Voclosporin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lupkynis US10286036 Protocol for treatment of lupus nephritis Dec 07, 2037 Aurinia
Lupkynis US11622991 Protocol for treatment of lupus nephritis Dec 07, 2037 Aurinia
Lupkynis US7332472 Cyclosporine analogue mixtures and their use as immunomodulating agents Oct 17, 2025 Aurinia



Voclosporin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List